Real-World Survival Outcomes Based on EGFR Mutation Status in Chinese Patients With Lung Adenocarcinoma After Complete Resection: Results From the ICAN Study

INTRODUCTION: The adjuvant treatment of patients with resected lung adenocarcinoma (LUAD) remains unstandardized. We analyzed the survival outcomes of these patients based on EGFR mutation status and adjuvant chemotherapy treatment. METHODS: This noninterventional real-world study (ICAN) enrolled Ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xue-Ning, Yan, Hong-Hong, Wang, Jun, Chu, Xiang-Yang, Liu, Zhi-Dong, Shen, Yi, Ma, Hai-Tao, Fu, Xiang-Ning, Hu, Jian, Zhou, Nai-Kang, Liu, Yong-Yu, Zhou, Xin-Ming, Li, Jing-Song, Yang, Kang, Li, Jian, Xu, Lin, Wang, Si-Yu, Wang, Qun, Liu, Lun-Xu, Xu, Shun, Chen, Zhong-Yuan, Lou, Hong-He, Wang, Chang-Li, Cheng, Ying, Liu, Si-Yang, Zhang, Xu-Chao, Zhong, Wen-Zhao, Wu, Yi-Long
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683612/
https://www.ncbi.nlm.nih.gov/pubmed/34977823
http://dx.doi.org/10.1016/j.jtocrr.2021.100257

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683612/
https://www.ncbi.nlm.nih.gov/pubmed/34977823
http://dx.doi.org/10.1016/j.jtocrr.2021.100257

Ejemplares similares